$18.02
-0.19-1.04%
Last update: Oct 9, 2:55 PM
$18.29
0.080.44%
Sarepta Therapeutics Inc
SRPTNASDAQ
Sarepta Therapeutics (SRPT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.46 | $0.91 | $-0.87 | $-0.46 |
| Actual | $0.64 | $3.16 | $-3.58 | $-0.13 |
| Surprise | +39.1% | +247.3% | -311.5% | +71.7% |
| Revenue | ||||
| Estimate | $364.4M | $473.6M | $398.0M | $343.3M |
| Actual | $401.3M | $730.8M | $442.9M | $399.4M |
| Surprise | +10.1% | +54.3% | +11.3% | +16.3% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.33 | $0.03 | $0.23 | $0.26 |
| Revenue | ||||
| Consensus | $352.8M | $351.7M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $0.64 | $0.46 | 39.1 % |
| Q1 | May 6, 2026 | $3.16 | $0.91 | 247.3 % |
| Q4 | Feb 25, 2026 | $-3.58 | $-0.87 | -311.5 % |
| Q3 | Nov 3, 2025 | $-0.13 | $-0.46 | 71.7 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $401.30M | $364.44M | 10.1 % |
| Q1 | May 6, 2026 | $730.80M | $473.58M | 54.3 % |
| Q4 | Feb 25, 2026 | $442.93M | $397.98M | 11.3 % |
| Q3 | Nov 3, 2025 | $399.36M | $343.25M | 16.3 % |
